ringer's solution for infusion 8,6 mg/0,3 mg/0,33 mg/ml soluţie perfuzabilă
tianjin sinomed pharmaceutical co., ltd. - natrii chloridum + amoxicillinum chloridum + calciu chloridum - soluţie perfuzabilă - 8,6 mg/0,3 mg/0,33 mg/ml
nylex®
proel e.p. coronis sa - grecia - calcitoninum (somon) - sol. inj. - 100ui/ml - preparate antihormoni paratiroidieni preparate continand calcitonina
miacalcic®
novartis pharma gmbh - calcitoninum (somon) - sol. inj. - 50ui/ml - preparate antihormoni paratiroidieni preparate continand calcitonina
antacid comprimate 500 mg
eurofarmaco sa, ics - calciu carbonas - comprimate - 500 mg
nylex 100 ui/doza
novendia pharmaceuticals ltd. - calcitoninum (somon) - spray naz.,sol. - 100ui/doza - preparate antihormoni paratiroidieni preparate continand calcitonina
vydura
pfizer europe ma eeig - rimegepant - tulburări ale migrenei - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
vyepti
h. lundbeck a/s - eptinezumab - tulburări ale migrenei - analgezice - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.
sandostatin solutie injectabila 0,05 mg/ml
novartis pharma ag - octreotidum - solutie injectabila - 0,05 mg/ml
sandostatin solutie injectabila 0,1 mg/ml
novartis pharma ag - octreotidum - solutie injectabila - 0,1 mg/ml
sandostatin lar 10 mg pulbere şi solvent pentru suspensie injectabilă cu eliberare prelungită
novartis pharma ag - octreotidum - pulbere şi solvent pentru suspensie injectabilă cu eliberare prelungită - 10 mg